Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-29,114
Closed -$2.71M 735
2020
Q2
$2.71M Sell
29,114
-131
-0.4% -$11.1K 0.08% 215
2020
Q1
$2.15M Sell
29,245
-2,109
-7% -$183K 0.07% 232
2019
Q4
$2.64M Sell
31,354
-226
-0.7% -$17.5K 0.07% 253
2019
Q3
$2.65M Buy
31,580
+451
+1% +$34.1K 0.08% 225
2019
Q2
$2.04M Buy
+31,129
New +$1.79M 0.06% 271

Other funds holding MEDP

Colony Group's MEDP Position: Q3 2020 in Review

Colony Group sold out of Medpace (MEDP) in Q3 2020, closing a stake of 29,114 shares — an estimated $2.71M sold.

Colony Group first reported a position in MEDP in Q2 2019 and held it in 5 quarters. The position peaked at $2.71M in Q2 2020. 310 funds tracked by Wall St. Rank hold MEDP as of Q3 2020.

  • Colony Group reported no remaining Medpace position as of Q3 2020 after selling out during the quarter.
  • Colony Group sold 29,114 Medpace shares in Q3 2020, an estimated $2.71M.
  • Colony Group first reported a position in Medpace in Q2 2019 and held it in 5 quarters.
  • Colony Group's Medpace position peaked at $2.71M in Q2 2020.
  • 310 funds tracked by Wall St. Rank held Medpace as of Q3 2020.

Based on Colony Group's 13F filing for Q3 2020, filed 17 Nov 2020.